Total Raised

$49.68M

Investors Count

4

Deal Terms

2

Funding, Valuation & Revenue

5 Fundings

Portal Instruments has raised $49.68M over 5 rounds.

Portal Instruments's latest funding round was a Series C for $7M on April 29, 2022.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/29/2022

Series C

$7M

$XXM

0

FY undefined

1

4/28/2020

Loan

$XXM

$XXM

0

FY undefined

0

10/20/2017

Series B - III

$XXM

$XXM

0

FY undefined

10

10/20/2015

Series B

$XXM

$XXM

0

FY undefined

10

10/15/2014

Series A

$XXM

$XXM

0

FY undefined

10

Date

4/29/2022

4/28/2020

10/20/2017

10/20/2015

10/15/2014

Round

Series C

Loan

Series B - III

Series B

Series A

Amount

$7M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

0

10

10

10

Start free trial
New call-to-action

Portal Instruments Deal Terms

2 Deal Terms

Portal Instruments's deal structure is available for 2 funding rounds, including their Series B from October 20, 2015.

Round

Series B

Series A

Funding Date

$XXM

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Series A

$XXM

$XXM

$XXM

$XXM

Portal Instruments Investors

4 Investors

Portal Instruments has 4 investors. 5AM Ventures invested in Portal Instruments's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/20/2015

4/29/2022

3
Series B, Series B - III (2017), Series C (2022)

Venture Capital

California

00/00/0000

00/00/0000

PBJ Capital

Subscribe to see more

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Paycheck Protection Program

Subscribe to see more

Government

DC

00/00/0000

00/00/0000

Sanofi

Subscribe to see more

Corporation

France

First funding

10/20/2015

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/29/2022

00/00/0000

00/00/0000

00/00/0000

Investor

PBJ Capital

Paycheck Protection Program

Sanofi

Rounds

3
Series B, Series B - III (2017), Series C (2022)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Government

Corporation

Location

California

Massachusetts

DC

France

New call-to-action

Compare Portal Instruments to Competitors

R
R4 Vascular

R4 Vascular focuses on the design and manufacturing of vascular access products within the medical device industry. The company provides products that enable access to patient vasculature for the delivery of chemotherapy, blood products, antibiotics, drugs, or nutrition, primarily used by clinicians including oncologists, interventional radiologists, surgeons, and nurses. It is based in Hoboken, New Jersey.

Ever Health Logo
Ever Health

Ever Health provides telemedicine services in the healthcare technology sector. The company has a telemedicine platform that includes digital consultations and remote diagnostics. Ever Health serves various sectors including enterprises, insurance companies, educational institutions, healthcare professionals, and senior care services. It was founded in 2013 and is based in Madrid, Spain.

S
Subcuject

Subcuject is a medical device company focused on developing drug delivery systems within the healthcare sector. Their main offerings include a Wearable Bolus Injector (WBI) that uses osmosis to facilitate subcutaneous injection of larger pharmaceutical volumes, and a Hands-Free Autoinjector aimed at patients with dexterity challenges. These devices are prefilled, feature automatic needle insertion and retraction, and are intended to work with pharmaceutical development processes. It is based in Hellebaek, Denmark.

Crossject Medical Technology Logo
Crossject Medical Technology

Crossject Medical Technology is a pharmaceutical company that develops needle-free auto-injectors for emergency situations. The company's main product, ZENEO4, is a pre-filled, single-use auto-injector designed for the delivery of emergency medications without needles. Crossject serves the healthcare sector, offering solutions for conditions such as epilepsy, allergic shocks, and adrenal insufficiencies. It was founded in 2001 and is based in France.

I
Iaculor Injection

Iaculor Injection Inc. develops low-cost, more efficient needle-free injection devices that allow the delivery of powder or liquid forms of vaccines, small molecules, and biologicals.

D
Depotech

Depotech is developing methods for drug delivery

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.